J&J COVID-19 Vaccine Wins Backing of FDA Panel

An FDA panel voted 22 to 0 in favor of an emergency clearance for Janssen/J&J’s COVID-19 vaccine, bringing it a step closer to distribution.
Medscape Medical News

Source link